Oxyblu Methylene Blue Injection USP 1% (10 mg/ml) - 5 x 10 ml

Oxyblu Methylene Blue Injection is a prescription medicine used primarily to treat methemoglobinemia, a rare but serious condition in which the blood cannot carry enough oxygen because of an abnormal form of hemoglobin. The active ingredient, methylene blue, works by helping convert methemoglobin back into normal hemoglobin, allowing red blood cells to transport oxygen efficiently throughout the body. Administered only through intravenous (IV) injection under the supervision of a healthcare professional, Oxyblu Methylene Blue Injection acts quickly to improve oxygen delivery and relieve symptoms such as bluish skin, shortness of breath, fatigue, dizziness, and confusion. In certain medical situations, it may also be used as directed by a doctor for specific diagnostic or therapeutic purposes.

Oxyblu Methylene Blue Injection is intended for use in hospitals or clinical settings, where the dose is carefully determined according to the patient's body weight, medical condition, and response to treatment. Prompt administration is important because untreated methemoglobinemia can reduce oxygen supply to vital organs and become life-threatening. Before receiving this medicine, patients should inform their doctor about any allergies, G6PD deficiency, kidney disease, or medications they are taking, as methylene blue may interact with certain drugs, especially antidepressants that increase serotonin levels. Regular monitoring during treatment helps ensure both effectiveness and safety while reducing the risk of complications.

Overall, Oxyblu Methylene Blue Injection is an effective emergency treatment that helps restore the blood's oxygen-carrying capacity and supports rapid recovery in patients with methemoglobinemia. Following the doctor's instructions and receiving the injection under proper medical supervision ensures the best possible treatment outcomes and patient safety.